Glaxosmithkline Plc Pandion Therapeutics, Inc. (PAND) insider trading activity

PAND Quotes by TradingView

GLAXOSMITHKLINE PLC Transaction History

Date Transaction Value Shares Traded Form
Jul 21 2020
BUY
Open market or private purchase
$6,499,998 $18.0 p/Share
361,111
Jul 21 2020
BUY
Conversion of derivative security
-
1,887,193

Also insider at

CRSP
CRISPR Therapeutics AG Healthcare
> 10% Shareholder
SPRO
Spero Therapeutics, Inc. Healthcare
> 10% Shareholder
TBIO
Translate Bio, Inc. Healthcare
> 10% Shareholder
LQDA
Liquidia Technologies Inc
PRNB
Principia Biopharma Inc.
CCXI
ChemoCentryx, Inc.
TPTX
Turning Point Therapeutics, Inc.
Director
BCYC
BICYCLE THERAPEUTICS plc Healthcare
> 10% Shareholder
GNCA
GENOCEA BIOSCIENCES, INC. Healthcare
> 10% Shareholder
MORF
Morphic Holding, Inc. Healthcare
Director
FULC
Fulcrum Therapeutics, Inc. Healthcare
PGNY
Progyny, Inc. Healthcare
> 10% Shareholder
NKTX
Nkarta, Inc. Healthcare
Director
DBTX
Decibel Therapeutics, Inc. Healthcare
Director
INVA
Innoviva, Inc. Healthcare
> 10% Shareholder
LYEL
Lyell Immunopharma, Inc. Healthcare
> 10% Shareholder
CVRX
CVRx, Inc. Healthcare
> 10% Shareholder
TBPH
Theravance Biopharma, Inc. Healthcare
WVE
Wave Life Sciences Ltd. Healthcare
> 10% Shareholder
GP

Glaxosmithkline PLC

Director
Brentford Middlesex, X0

Track Institutional and Insider Activities on PAND

Follow Pandion Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PAND shares.

Notify only if

Insider Trading

Get notified when an Pandion Therapeutics, Inc. insider buys or sells PAND shares.

Notify only if

News

Receive news related to Pandion Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on PAND